Thorne Healthtech, Inc. (THRN) Social Stream
THORNE HEALTHTECH INC (THRN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering THORNE HEALTHTECH INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 4 | $13 | $11 | $11.5 | $10.19 | 12.86% |
| 2022-03-17 | 4 | $13 | $11 | $11.75 | $10.19 | 15.31% |
| 2022-05-16 | 4 | $13 | $8 | $11 | $10.19 | 7.95% |
| 2022-09-22 | 3 | $8 | $7 | $7.666 | $10.19 | -24.77% |
| 2022-11-15 | 3 | $8 | $6 | $7 | $10.19 | -31.31% |
| 2023-01-26 | 4 | $8 | $5.5 | $6.625 | $10.19 | -34.99% |
| 2023-02-23 | 4 | $8.001 | $5.5 | $6.625 | $10.19 | -34.99% |
| 2023-04-04 | 4 | $8.001 | $5.5 | $6.375 | $10.19 | -37.44% |
| 2023-07-21 | 4 | $8.001 | $6 | $6.5 | $10.19 | -36.21% |
| 2023-08-11 | 4 | $8.001 | $6 | $6.75 | $10.19 | -33.76% |
| 2023-08-30 | 3 | $10.2 | $6 | $7.3 | $10.19 | -28.36% |
The Trend in the Analyst Price Target
Over the past 22 months, THRN's average price target has gone down $4.2.
THRN reports an average of 31.32% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-11 | 3 | 8.000 | 6.0 | 7.000 | 3.53 | 98.3% |
| 2023-01-26 | 4 | 8.000 | 5.5 | 6.625 | 4.15 | 59.64% |
| 2023-05-12 | 4 | 8.001 | 6.0 | 6.500 | 4.88 | 33.2% |
| 2023-07-21 | 4 | 8.001 | 6.0 | 6.500 | 5.95 | 9.24% |
| 2023-08-11 | 4 | 8.001 | 6.0 | 6.750 | 6.92 | -2.46% |
THRN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.75 | 0 | 1 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
THRN's average broker recommendation rating worsened by 0.75 over the prior 92 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- THORNE HEALTHTECH INC's upside potential (average analyst target price relative to current price) is higher than 109.88% of all US stocks.
- In terms of how THORNE HEALTHTECH INC fares relative to all US stocks, note that its average analyst price target is greater than 120.66% of that group.
- In the context of Consumer Defensive stocks, THORNE HEALTHTECH INC's number of analysts covering the stock is higher than 175.87% of them.
- THRN has a lower variance in analysts' estimates than -221.4% of Pharmaceutical Products stocks.
Stocks similar to THORNE HEALTHTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are THRX, PYXS, and XLO.
View All Top Stocks by Price Target
Is THRN a Buy, Hold or Sell? See the POWR Ratings now!